Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis

Clinical Rheumatology

Volumn 24, Issue 3, 2005, Pages 278-284

  Wislowska M ^a   Jablonska B ^a  

^a CENTRAL CLINICAL HOSPITAL   (Poland)

Author keywords

Cartilage; Knee osteoarthritis; Rheumatoid arthritis; Serum cartilage oligomeric matrix protein (COMP)

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CYCLOSPORIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGE; AGED; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; BONE MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MALE; MORNING STIFFNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RATING SCALE; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SCORING SYSTEM; STATISTICAL ANALYSIS; SYNOVIAL FLUID;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE DENSITY; DENSITOMETRY, X-RAY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX;

EID: 20944444066     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1000-x     Document Type: Article

References (28)

1. Saxne T, Heinegard D (1992) Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31:583-591 1:STN:280:By2H3cvos1c%3D
2. Morgelin M, Heinegard D, Engel J, Paulsson M (1992) Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 267:6137-614 11:STN:280:By2B3M%2FlvVI%3D
3. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D (1992) Cartilage matrix proteins: An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132-6136 1:CAS:528:DyaK38XhvV2rt7s%3D
4. Franzen A, Heinegard D, Solursh M (1997) Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells. Differentiation 36:199-210
5. DiCesare P, Morgelin M, Mann K, Paulsson M (1994) Cartilage oligomeric matrix protein and thrombospondin. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 223:927-937 1:CAS:528:DyaK2cXlt1yhsLc%3D
6. Wollheim FA, Eberhardt KB, Johnson U, Saxne T (1997) HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Br J Rheumatol 36:847-849 10.1093/rheumatology/36.8.847
7. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegard D, Saxne T (1995) Cartilage and metabolism in rheumatoid arthritis. J Clin Invest 95:1071-1077 1:STN:280:ByqC1M%2FgtVU%3D
8. Forslind K, Eberhardt K, Jonsson A, Saxne T (1992) Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 31:593-598 1:STN:280:By2H3cvos1A%3D
9. Lindquist EK, Saxne T, Eberhard K (2002) Relationship between functional capacity, disease activity, pain and joint destruction during the first 10 years of rheumatoid arthritis. Ann Rheum Dis 61 [Suppl 1]:74
10. Fex E, Eberhardt K, Saxne T (1997) Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Rheumatol 36:1161-1165 10.1093/rheumatology/36.11.1161
11. Peterson IF, Boegard T, Dahlstrom J, Svensson B, Heinegard D, Saxne T (1996) Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis Cartilage 6:33-39 10.1053/joca.1997.0090
12. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10:707-713 10.1053/joca.2002.0819
13. Haberhauer GF, Feyertag J, Kittl EM, Bauer K, Dunky A (2002) Steroid treatment normalises the variability and levels of serum COMP in RA patients, indicating a possibility to monitor effect of cartilage protective drugs. Rheum Dis 61 [Suppl 1]:200
14. Haberhauer GF, Feyertag J, Kitti EM, Bauer K, Dunky A (2003) Rapid decrease of COMP serum levels in patients with active RA undergoing IV steroid treatment. Ann Rheum Dis 62 [Suppl 1]:166
15. Crnkic M, Masson B, Larsson L, Geborek P, Heinegard D, Saxne T (2003) Serum cartilage oligomeric matrix protein (COMP) decreased in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 5:R181-R185 10.1186/ar760
16. Den Broeder AA, Jonsten LAB, Saxne T, Heinegard D, Fenner H, Miltenburg AMM, Frasa WLH, van Tils LJ, Burman WA, van Riel PLCM, van de Putte LBA, Barrera P (2002) Long term anti-tumor necrosis factor alfa monotherapy in rheumatoid arthritis: Effect on radiological course and endothelial activation. Ann Rheum Dis 61:311-318 10.1136/ard.61.4.311
17. Neidhart M, Hauser N, Paulsson M et al (1997) Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151-1160 10.1093/ rheumatology/36.11.1151 10.1093/rheumatology/36.11.1151
18. Dahlberg L, Roos H, Saxne T et al (1994) Cartilage metabolism in the uninjured knee of the same patient. Ann Rheum Dis 53:823-827 1:STN:280:ByqC28fpt1w%3D 1:STN:280:ByqC28fpt1w%3D
19. Saxne T, Heinegard D (1992) Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood (published erratum appears in Br J Rheumatol 32:247). Br J Rheumatol 31:583-591 1:STN:280:By2H3cvos1c%3D
20. Arnett FC (1989) Revised criteria for the classification of rheumatoid arthritis. Bul Rheum Dis 38:1-6 1:STN:280:By%2BD38bhvVU%3D
21. Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662
22. van der Heijde DMFM, van't Hof MA, van Riel PLCM, van de Putte LBA (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20:579-581 8478878
23. Altman R (1991) Classification of disease: Osteoarthritis. Semin Arthritis Rheum 21 [Suppl 2]:40-47 10.1016/0049-0172(91)90026-V
24. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LWJ (1988) Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840 1:STN:280:BiaC2MjkvVc%3D
25. Kellgren JH, Lawrence SJ (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502 1:STN:280:CyeD2c7js1M%3D
26. Robert R, Sokal F, Rohlf J (1986) Biometry. Freeman, New York, pp 354-359, 691-714
27. Marti C, Neidhart M, Gerber T et al (1999) Cartilage oligomeric matrix protein (COMP). Die Rolle eines nichtkollagenem Knorpel-Matrix-Proteins als Marker der Krankheitsaktivität und Gelenkzerstörung bei Patienten mit rheumatoider Arthritis und Arthrose. Z Rheumatol 58:78-87 10.1007/s003930050156
28. Feyertag J, Haberhauer GF, Kittl EM et al (2002) Changes in clinical scorings are correlated to changes in cartilage oligomeric matrix protein (COMP) levels, but not to systemic inflammation markers in patients with rheumatoid arthritis (RA). Ann Rheum Dis 61 [Suppl 1]:75